erythrocentaurin has been researched along with tenofovir in 1 studies
| Studies (erythrocentaurin) | Trials (erythrocentaurin) | Recent Studies (post-2010) (erythrocentaurin) | Studies (tenofovir) | Trials (tenofovir) | Recent Studies (post-2010) (tenofovir) |
|---|---|---|---|---|---|
| 9 | 0 | 5 | 5,178 | 940 | 3,806 |
| Protein | Taxonomy | erythrocentaurin (IC50) | tenofovir (IC50) |
|---|---|---|---|
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.38 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JJ; Geng, CA; Huang, XY; Ma, YB; Zhang, XM | 1 |
1 other study(ies) available for erythrocentaurin and tenofovir
| Article | Year |
|---|---|
Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Hep G2 Cells; Hepatitis B virus; Humans; Isocoumarins; Microbial Sensitivity Tests; Molecular Structure | 2015 |